{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T07:38:45Z","timestamp":1648885125415},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s11886-018-0945-3","type":"journal-article","created":{"date-parts":[[2018,1,29]],"date-time":"2018-01-29T03:27:02Z","timestamp":1517196422000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Contemporary Perspectives in Durable Mechanical Circulatory Support: What Did We Learn in the Last 3\u00a0Years?"],"prefix":"10.1007","volume":"20","author":[{"given":"Jayant","family":"Raikhelkar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nir","family":"Uriel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,29]]},"reference":[{"issue":"12","key":"945_CR1","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.healun.2015.10.003","volume":"34","author":"JK Kirklin","year":"2015","unstructured":"Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Stevenson LW, Blume ED, et al. Seventh INTERMACS annual report: 15,000 patients and counting. J Heart Lung Transpl. 2015;34(12):1495\u2013504. \n                      https:\/\/doi.org\/10.1016\/j.healun.2015.10.003\n                      \n                    .","journal-title":"J Heart Lung Transpl"},{"issue":"9","key":"945_CR2","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1056\/NEJMoa067758","volume":"357","author":"LW Miller","year":"2007","unstructured":"Miller LW, Pagani FD, Russell SD, John R, Boyle AJ, Aaronson KD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357(9):885\u201396. \n                      https:\/\/doi.org\/10.1056\/NEJMoa067758\n                      \n                    .","journal-title":"N Engl J Med"},{"issue":"23","key":"945_CR3","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1056\/NEJMoa0909938","volume":"361","author":"MS Slaughter","year":"2009","unstructured":"Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361(23):2241\u201351. \n                      https:\/\/doi.org\/10.1056\/NEJMoa0909938\n                      \n                    .","journal-title":"N Engl J Med"},{"issue":"17","key":"945_CR4","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1016\/j.jacc.2014.01.053","volume":"63","author":"UP Jorde","year":"2014","unstructured":"Jorde UP, Kushwaha SS, Tatooles AJ, Naka Y, Bhat G, Long JW, et al. Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol. 2014;63(17):1751\u20137. \n                      https:\/\/doi.org\/10.1016\/j.jacc.2014.01.053\n                      \n                    .","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"945_CR5","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.healun.2016.09.002","volume":"35","author":"FD Pagani","year":"2016","unstructured":"Pagani FD, Aaronson KD, Kormos R, Mann DL, Spino C, Jeffries N, et al. The NHLBI REVIVE-IT study: understanding its discontinuation in the context of current left ventricular assist device therapy. J Heart Lung Transpl. 2016;35(11):1277\u201383. \n                      https:\/\/doi.org\/10.1016\/j.healun.2016.09.002\n                      \n                    .","journal-title":"J Heart Lung Transpl"},{"issue":"1","key":"945_CR6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1056\/NEJMoa1313385","volume":"370","author":"RC Starling","year":"2014","unstructured":"Starling RC, Moazami N, Silvestry SC, Ewald G, Rogers JG, Milano CA, et al. Unexpected abrupt increase in left ventricular assist device thrombosis. N Engl J Med. 2014;370(1):33\u201340. \n                      https:\/\/doi.org\/10.1056\/NEJMoa1313385\n                      \n                    .","journal-title":"N Engl J Med"},{"issue":"16","key":"945_CR7","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/j.jacc.2015.07.075","volume":"66","author":"JD Estep","year":"2015","unstructured":"Estep JD, Starling RC, Horstmanshof DA, Milano CA, Selzman CH, Shah KB, et al. Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: results from the ROADMAP study. J Am Coll Cardiol. 2015;66(16):1747\u201361. \n                      https:\/\/doi.org\/10.1016\/j.jacc.2015.07.075\n                      \n                    .","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"945_CR8","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.jchf.2017.02.016","volume":"5","author":"RC Starling","year":"2017","unstructured":"Starling RC, Estep JD, Horstmanshof DA, Milano CA, Stehlik J, Shah KB, et al. Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: the ROADMAP study 2-year results. JACC Heart Fail. 2017;5(7):518\u201327. \n                      https:\/\/doi.org\/10.1016\/j.jchf.2017.02.016\n                      \n                    .","journal-title":"JACC Heart Fail"},{"issue":"4","key":"945_CR9","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.healun.2013.12.014","volume":"33","author":"SM Dunlay","year":"2014","unstructured":"Dunlay SM, Park SJ, Joyce LD, Daly RC, Stulak JM, McNallan SM, et al. Frailty and outcomes after implantation of left ventricular assist device as destination therapy. J Heart Lung Transpl. 2014;33(4):359\u201365. \n                      https:\/\/doi.org\/10.1016\/j.healun.2013.12.014\n                      \n                    .","journal-title":"J Heart Lung Transpl"},{"issue":"5","key":"945_CR10","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.cardfail.2014.02.008","volume":"20","author":"CJ Chung","year":"2014","unstructured":"Chung CJ, Wu C, Jones M, Kato TS, Dam TT, Givens RC, et al. Reduced handgrip strength as a marker of frailty predicts clinical outcomes in patients with heart failure undergoing ventricular assist device placement. J Card Fail. 2014;20(5):310\u20135. \n                      https:\/\/doi.org\/10.1016\/j.cardfail.2014.02.008\n                      \n                    .","journal-title":"J Card Fail"},{"key":"945_CR11","doi-asserted-by":"publisher","unstructured":"Cooper LB, Hammill BG, Allen LA, Lindenfeld J, Mentz RJ, Rogers JG, et al. Assessing frailty in patients undergoing destination therapy left ventricular assist device: observations from Interagency Registry for Mechanically Assisted Circulatory Support. ASAIO J. 2017. \n                      https:\/\/doi.org\/10.1097\/MAT.0000000000000600\n                      \n                    .","DOI":"10.1097\/MAT.0000000000000600"},{"issue":"5","key":"945_CR12","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1056\/NEJMoa1602954","volume":"376","author":"JG Rogers","year":"2017","unstructured":"\u2022\u2022 Rogers JG, Pagani FD, Tatooles AJ, Bhat G, Slaughter MS, Birks EJ, et al. Intrapericardial left ventricular assist device for advanced heart failure. New Engl J Med. 2017;376(5):451\u201360. This study describes the primary findings of the ENDURANCE study in which the use of the Heartware device was compared to Heartmate II","journal-title":"New Engl J Med"},{"issue":"23","key":"945_CR13","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1016\/j.jacc.2015.09.083","volume":"66","author":"I Netuka","year":"2015","unstructured":"Netuka I, Sood P, Pya Y, Zimpfer D, Krabatsch T, Garbade J, et al. Fully magnetically levitated left ventricular assist system for treating advanced HF: a multicenter study. J Am Coll Cardiol. 2015;66(23):2579\u201389. \n                      https:\/\/doi.org\/10.1016\/j.jacc.2015.09.083\n                      \n                    .","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"945_CR14","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1056\/NEJMoa1610426","volume":"376","author":"MR Mehra","year":"2017","unstructured":"\u2022\u2022 Mehra MR, Naka Y, Uriel N, Goldstein DJ, Cleveland JC Jr, Colombo PC, et al. A fully magnetically levitated circulatory pump for advanced heart failure. New Engl J Med. 2017;376(5):440\u2013450. This study describes the primary findings of the MOMEMTUM 3 trial in which the use of the Heartmate 3 device was compared to HeartMate II. \n                      https:\/\/doi.org\/10.1056\/NEJMoa1610426\n                      \n                    .","journal-title":"New Engl J Med"},{"key":"945_CR15","doi-asserted-by":"publisher","unstructured":"Mehra MR. The burden of haemocompatibility with left ventricular assist systems: a complex weave. Eur Heart J. 2017. \n                      https:\/\/doi.org\/10.1093\/eurheartj\/ehx036\n                      \n                    .","DOI":"10.1093\/eurheartj\/ehx036"},{"issue":"21","key":"945_CR16","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1161\/CIRCULATIONAHA.117.028303","volume":"135","author":"N Uriel","year":"2017","unstructured":"\u2022\u2022 Uriel N, Colombo PC, Cleveland JC, Long JW, Salerno C, Goldstein DJ, et al. Hemocompatibility-related outcomes in the MOMENTUM 3 trial at 6 months: a randomized controlled study of a fully magnetically levitated pump in advanced heart failure. Circulation. 2017;135(21):2003\u20132012. This study describes the use of the hemocompatibility score. \n                      https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.028303\n                      \n                    .","journal-title":"Circulation"},{"issue":"15","key":"945_CR17","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.jacc.2010.05.016","volume":"56","author":"N Uriel","year":"2010","unstructured":"Uriel N, Pak SW, Jorde UP, Jude B, Susen S, Vincentelli A, et al. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. J Am Coll Cardiol. 2010;56(15):1207\u201313. \n                      https:\/\/doi.org\/10.1016\/j.jacc.2010.05.016\n                      \n                    .","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"945_CR18","first-page":"849","volume":"30","author":"ZT Demirozu","year":"2011","unstructured":"Demirozu ZT, Radovancevic R, Hochman LF, Gregoric ID, Letsou GV, Kar B, et al. Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device. J Heart Lung Transpl. 2011;30(8):849\u201353.","journal-title":"J Heart Lung Transpl"},{"issue":"3","key":"945_CR19","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1161\/CIRCHEARTFAILURE.112.000206","volume":"6","author":"O Wever-Pinzon","year":"2013","unstructured":"Wever-Pinzon O, Selzman CH, Drakos SG, Saidi A, Stoddard GJ, Gilbert EM, et al. Pulsatility and the risk of nonsurgical bleeding in patients supported with the continuous-flow left ventricular assist device HeartMate II. Circ Heart Fail. 2013;6(3):517\u201326. \n                      https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.112.000206\n                      \n                    .","journal-title":"Circ Heart Fail"},{"issue":"12","key":"945_CR20","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.jchf.2016.08.005","volume":"4","author":"SR Patel","year":"2016","unstructured":"Patel SR, Madan S, Saeed O, Algodi M, Luke A, Gibber M, et al. Association of nasal mucosal vascular alterations, gastrointestinal arteriovenous malformations, and bleeding in patients with continuous-flow left ventricular assist devices. JACC Heart Fail. 2016;4(12):962\u201370. \n                      https:\/\/doi.org\/10.1016\/j.jchf.2016.08.005\n                      \n                    .","journal-title":"JACC Heart Fail"},{"issue":"2","key":"945_CR21","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1161\/CIRCULATIONAHA.115.019692","volume":"134","author":"CE Tabit","year":"2016","unstructured":"Tabit CE, Chen P, Kim GH, Fedson SE, Sayer G, Coplan MJ, et al. Elevated angiopoietin-2 level in patients with continuous-flow left ventricular assist devices leads to altered angiogenesis and is associated with higher nonsurgical bleeding. Circulation. 2016;134(2):141\u201352. \n                      https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.019692\n                      \n                    .","journal-title":"Circulation"},{"issue":"4","key":"945_CR22","doi-asserted-by":"publisher","first-page":"S121","DOI":"10.1016\/j.healun.2017.01.313","volume":"36","author":"CE Tabit","year":"2017","unstructured":"Tabit CE, Coplan MJ, Chen P, Jeevanandam V, Uriel N, Liao JK. Tumor necrosis factor-alpha levels and non-surgical bleeding in continuous-flow left ventricular assist devices. J Heart Lung Transpl. 2017;36(4):S121\u20132. \n                      https:\/\/doi.org\/10.1016\/j.healun.2017.01.313\n                      \n                    .","journal-title":"J Heart Lung Transpl"},{"issue":"6","key":"945_CR23","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.healun.2016.12.010","volume":"36","author":"JA Frontera","year":"2017","unstructured":"Frontera JA, Starling R, Cho SM, Nowacki AS, Uchino K, Hussain MS, et al. Risk factors, mortality, and timing of ischemic and hemorrhagic stroke with left ventricular assist devices. J Heart Lung Transpl. 2017;36(6):673\u201383. \n                      https:\/\/doi.org\/10.1016\/j.healun.2016.12.010\n                      \n                    .","journal-title":"J Heart Lung Transpl."},{"issue":"10","key":"945_CR24","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.jchf.2015.05.011","volume":"3","author":"JJ Teuteberg","year":"2015","unstructured":"Teuteberg JJ, Slaughter MS, Rogers JG, McGee EC, Pagani FD, Gordon R, et al. The HVAD left ventricular assist device: risk factors for neurological events and risk mitigation strategies. JACC Heart Fail. 2015;3(10):818\u201328. \n                      https:\/\/doi.org\/10.1016\/j.jchf.2015.05.011\n                      \n                    .","journal-title":"JACC Heart Fail"},{"issue":"12","key":"945_CR25","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.healun.2015.06.018","volume":"34","author":"JN Katz","year":"2015","unstructured":"Katz JN, Adamson RM, John R, Tatooles A, Sundareswaran K, Kallel F, et al. Safety of reduced anti-thrombotic strategies in HeartMate II patients: a one-year analysis of the US-TRACE study. J Heart Lung Transpl. 2015;34(12):1542\u20138. \n                      https:\/\/doi.org\/10.1016\/j.healun.2015.06.018\n                      \n                    .","journal-title":"J Heart Lung Transpl."},{"issue":"1","key":"945_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.healun.2016.10.001","volume":"36","author":"S Maltais","year":"2017","unstructured":"\u2022 Maltais S, Kilic A, Nathan S, Keebler M, Emani S, Ransom J, et al. PREVENtion of HeartMate II pump thrombosis through clinical management: the PREVENT multi-center study. J Heart Lung Transpl. 2017;36(1):1\u201312. This study describes the utilization of surgical and medical protocols to decrease the incidence of LVAD thrombosis in patients implanted with Heartmate II","journal-title":"J Heart Lung Transpl"},{"issue":"1","key":"945_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.healun.2013.12.001","volume":"33","author":"SS Najjar","year":"2014","unstructured":"Najjar SS, Slaughter MS, Pagani FD, Starling RC, McGee EC, Eckman P, et al. An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial. J Heart Lung Transpl. 2014;33(1):23\u201334. \n                      https:\/\/doi.org\/10.1016\/j.healun.2013.12.001\n                      \n                    .","journal-title":"J Heart Lung Transpl"},{"issue":"11","key":"945_CR28","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.jchf.2015.06.015","volume":"3","author":"UP Jorde","year":"2015","unstructured":"Jorde UP, Aaronson KD, Najjar SS, Pagani FD, Hayward C, Zimpfer D, et al. Identification and management of pump thrombus in the HeartWare left ventricular assist device system: a novel approach using log file analysis. JACC Heart Fail. 2015;3(11):849\u201356. \n                      https:\/\/doi.org\/10.1016\/j.jchf.2015.06.015\n                      \n                    .","journal-title":"JACC Heart Fail"},{"issue":"5","key":"945_CR29","doi-asserted-by":"publisher","first-page":"e002896","DOI":"10.1161\/CIRCHEARTFAILURE.115.002896","volume":"9","author":"AP Levin","year":"2016","unstructured":"Levin AP, Saeed O, Willey JZ, Levin CJ, Fried JA, Patel SR, et al. Watchful waiting in continuous-flow left ventricular assist device patients with ongoing hemolysis is associated with an increased risk for cerebrovascular accident or death. Circ Heart Fail. 2016;9(5):e002896. \n                      https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.115.002896\n                      \n                    .","journal-title":"Circ Heart Fail"},{"issue":"2","key":"945_CR30","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1161\/CIRCHEARTFAILURE.113.000878","volume":"7","author":"UP Jorde","year":"2014","unstructured":"Jorde UP, Uriel N, Nahumi N, Bejar D, Gonzalez-Costello J, Thomas SS, et al. Prevalence, significance, and management of aortic insufficiency in continuous flow left ventricular assist device recipients. Circ Heart Fail. 2014;7(2):310\u20139. \n                      https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.113.000878\n                      \n                    .","journal-title":"Circ Heart Fail"},{"issue":"10","key":"945_CR31","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.healun.2010.05.018","volume":"29","author":"SW Pak","year":"2010","unstructured":"Pak SW, Uriel N, Takayama H, Cappleman S, Song R, Colombo PC, et al. Prevalence of de novo aortic insufficiency during long-term support with left ventricular assist devices. J Heart Lung Transpl. 2010;29(10):1172\u20136. \n                      https:\/\/doi.org\/10.1016\/j.healun.2010.05.018\n                      \n                    .","journal-title":"J Heart Lung Transpl"},{"issue":"6","key":"945_CR32","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1161\/CIRCHEARTFAILURE.109.917765","volume":"3","author":"J Cowger","year":"2010","unstructured":"Cowger J, Pagani FD, Haft JW, Romano MA, Aaronson KD, Kolias TJ. The development of aortic insufficiency in left ventricular assist device-supported patients. Circ Heart Fail. 2010;3(6):668\u201374. \n                      https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.109.917765\n                      \n                    .","journal-title":"Circ Heart Fail"},{"issue":"4","key":"945_CR33","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1097\/MAT.0b013e318251cfff","volume":"58","author":"B Soleimani","year":"2012","unstructured":"Soleimani B, Haouzi A, Manoskey A, Stephenson ER, El-Banayosy A, Pae WE. Development of aortic insufficiency in patients supported with continuous flow left ventricular assist devices. ASAIO J. 2012;58(4):326\u20139. \n                      https:\/\/doi.org\/10.1097\/MAT.0b013e318251cfff\n                      \n                    .","journal-title":"ASAIO J"},{"issue":"12","key":"945_CR34","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.healun.2014.06.008","volume":"33","author":"JA Cowger","year":"2014","unstructured":"Cowger JA, Aaronson KD, Romano MA, Haft J, Pagani FD. Consequences of aortic insufficiency during long-term axial continuous-flow left ventricular assist device support. J Heart Lung Transpl. 2014;33(12):1233\u201340. \n                      https:\/\/doi.org\/10.1016\/j.healun.2014.06.008\n                      \n                    .","journal-title":"J Heart Lung Transpl"},{"issue":"8","key":"945_CR35","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.healun.2016.05.009","volume":"35","author":"J Grinstein","year":"2016","unstructured":"Grinstein J, Kruse E, Sayer G, Fedson S, Kim GH, Sarswat N, et al. Novel echocardiographic parameters of aortic insufficiency in continuous-flow left ventricular assist devices and clinical outcome. J Heart Lung Transpl. 2016;35(8):976\u201385. \n                      https:\/\/doi.org\/10.1016\/j.healun.2016.05.009\n                      \n                    .","journal-title":"J Heart Lung Transpl"},{"issue":"6","key":"945_CR36","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.jcmg.2015.06.020","volume":"9","author":"J Grinstein","year":"2016","unstructured":"Grinstein J, Kruse E, Sayer G, Fedson S, Kim GH, Jorde UP, et al. Accurate quantification methods for aortic insufficiency severity in patients with LVAD: role of diastolic flow acceleration and systolic-to-diastolic peak velocity ratio of outflow cannula. JACC Cardiovasc Imaging. 2016;9(6):641\u201351. \n                      https:\/\/doi.org\/10.1016\/j.jcmg.2015.06.020\n                      \n                    .","journal-title":"JACC Cardiovasc Imaging"},{"issue":"7","key":"945_CR37","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.cardfail.2017.04.012","volume":"23","author":"G Sayer","year":"2017","unstructured":"Sayer G, Sarswat N, Kim GH, Adatya S, Medvedofsky D, Rodgers D, et al. The hemodynamic effects of aortic insufficiency in patients supported with continuous-flow left ventricular assist devices. J Card Fail. 2017;23(7):545\u201351. \n                      https:\/\/doi.org\/10.1016\/j.cardfail.2017.04.012\n                      \n                    .","journal-title":"J Card Fail"},{"issue":"9","key":"945_CR38","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.healun.2015.06.015","volume":"34","author":"BC Lampert","year":"2015","unstructured":"Lampert BC, Teuteberg JJ. Right ventricular failure after left ventricular assist devices. J Heart Lung Transpl. 2015;34(9):1123\u201330. \n                      https:\/\/doi.org\/10.1016\/j.healun.2015.06.015\n                      \n                    .","journal-title":"J Heart Lung Transpl"},{"issue":"1","key":"945_CR39","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.healun.2016.08.010","volume":"36","author":"JD Rich","year":"2017","unstructured":"Rich JD, Gosev I, Patel CB, Joseph S, Katz JN, Eckman PM, et al. The incidence, risk factors, and outcomes associated with late right-sided heart failure in patients supported with an axial-flow left ventricular assist device. J eart Lung Transpl. 2017;36(1):50\u20138. \n                      https:\/\/doi.org\/10.1016\/j.healun.2016.08.010\n                      \n                    .","journal-title":"J eart Lung Transpl"},{"key":"945_CR40","doi-asserted-by":"publisher","unstructured":"Grinstein J, Rodgers D, Kalantari S, Sayer G, Kim GH, Sarswat N, Adatya S, Ota T, Jeevanandam V, Burkhoff D, Uriel N HVAD waveform analysis as a noninvasive marker of pulmonary capillary wedge pressure: a first step toward the development of a smart left ventricular assist device pump. ASAIO J. 2017. \n                      https:\/\/doi.org\/10.1097\/MAT.0000000000000604\n                      \n                    .","DOI":"10.1097\/MAT.0000000000000604"},{"issue":"4","key":"945_CR41","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.athoracsur.2013.10.107","volume":"97","author":"JX Wang","year":"2014","unstructured":"Wang JX, Smith JR, Bonde P. Energy transmission and power sources for mechanical circulatory support devices to achieve total implantability. Ann Thorac Surg. 2014;97(4):1467\u201374. \n                      https:\/\/doi.org\/10.1016\/j.athoracsur.2013.10.107\n                      \n                    .","journal-title":"Ann Thorac Surg"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11886-018-0945-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-018-0945-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-018-0945-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T19:30:58Z","timestamp":1548703858000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11886-018-0945-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["945"],"URL":"https:\/\/doi.org\/10.1007\/s11886-018-0945-3","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"29 January 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Jayant Raikhelkar declares that he has no conflict of interest.Nir Uriel is a consultant to Abbott Medical and Medtronic.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"6"}}